View Post

Drug is promising against pancreatic and breast cancers

In Clinical Trials by Barbara Jacoby

Source: Georgia State University From: eurekalert.org ProAgio, created from a human protein, targets the cell surface receptor integrin αVβ?, which is expressed on cancer-associated fibroblasts ProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in mice, according to a study published in the journal Cellular …